Director of PTC Medical (Pvt.) Ltd. – Gihan Beneragama, has clarified to ‘Sri Lanka Mirror’ that his firm didn’t import the Ondansetron Injection (Ondanman 8, USP 8 mg/4 ml), which was lately ordered withdrawn by the Nationwide Medicines Regulatory Authority (NMRA).
The injection is manufactured by Maan Prescription drugs Ltd of India.
He acknowledged that the drug was imported by the State Prescription drugs Company (SPC), with PTC Medical (Pvt.) Ltd., solely performing because the native agent.
He added that each one info requested by the NMRA can be supplied inside the required timeline and that, for additional particulars, it’s best to contact the NMRA instantly.
When ‘Sri Lanka Mirror’ contacted NMRA Chairperson – Dr. Ananda Wijewickrema concerning Beneragama’s assertion, he mentioned that the NMRA had knowledgeable the related firm in writing, as it’s registered with the NMRA because the importer of the drug.
Dr. Ananda Wijewickrema acknowledged that the choice was made primarily based on the suspicion that these issues had been attributable to an error within the manufacturing of the injection.
He added that a number of batches of the injection had been suspended following suspicions of contamination and complaints from a number of hospitals.
SPC Chairman declines to remark
‘Sri Lanka Mirror’ additionally made a number of makes an attempt to contact SPC Chairman – Manuj C. Weerasinghe concerning this incident, however was unsuccessful.
Later, a spokesperson acknowledged the Chairman had declined to remark and prompt contacting the Secretary to the Ministry of Well being and Mass Media for particulars.
2 deaths linked to Ondansetron – Minister
In the meantime, talking at yesterday’s (Dec. 16) cupboard briefing, Minister of Well being and Mass Media – Dr. Nalinda Jayatissa acknowledged that 02 deaths that are suspected to be linked to Ondansetron use had occurred on the Infectious Illnesses Hospital (IDH).
The injection has been briefly withdrawn, and a proper investigation is underway, he added.
NMRA suspends MAAN Prescription drugs’ merchandise
In the meantime, the NMRA yesterday withheld issued a letter to PTC Medical (Pvt.) Ltd. urging the corporate to instantly withhold all parenteral merchandise manufactured by Maan Prescription drugs Ltd, as a precautionary motion, till additional investigations.
📌 Associated Information:
